History of the development of corticosteroid therapy, Clin Exp Rheumatol. oct, vol.29, issue.5, pp.5-12, 2011. ,
Osteoporosis management among chronic glucocorticoid users: a systematic review, J Popul Ther Clin Pharmacol J Ther Popul Pharamcologie Clin, vol.21, issue.3, pp.486-504, 2014. ,
Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment, Biotechnology & Biotechnological Equipment, vol.26, issue.6, pp.1127-1164, 2014. ,
DOI : 10.1002/art.23417
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.1, pp.117-140, 2001. ,
DOI : 10.1210/jc.86.1.117
The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics, European Journal of Endocrinology, vol.165, issue.3, pp.383-92, 2011. ,
DOI : 10.1530/EJE-11-0272
Cushing's syndrome, The Lancet, vol.386, issue.9996, pp.913-940, 2015. ,
DOI : 10.1016/S0140-6736(14)61375-1
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.100, issue.8, pp.2807-2838, 2015. ,
DOI : 10.1210/jc.2015-1818
Subclinical hypercortisolism in adrenal incidentaloma, Current Opinion in Endocrinology & Diabetes and Obesity, vol.22, issue.3, pp.185-92, 2015. ,
DOI : 10.1097/MED.0000000000000151
Prognostic factors in stage III???IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study, Annals of Oncology, vol.26, issue.10, pp.2119-2144, 2015. ,
DOI : 10.1093/annonc/mdv329
Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.3, pp.632-674, 2011. ,
DOI : 10.1210/jc.2010-1942
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects, European Journal of Endocrinology, vol.167, issue.3, pp.311-337, 2012. ,
DOI : 10.1530/EJE-11-1095
Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.3, pp.632-674, 2011. ,
DOI : 10.1210/jc.2010-1942
Glucocorticoid-induced osteoporosis: pathophysiology and therapy, Osteoporosis International, vol.89, issue.10, pp.1319-1347, 2007. ,
DOI : 10.7326/0003-4819-125-12-199612150-00004
Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids., Molecular and Cellular Biology, vol.16, issue.8, pp.4128-4164, 1996. ,
DOI : 10.1128/MCB.16.8.4128
Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation, Developmental Cell, vol.8, issue.5, pp.751-64, 2005. ,
DOI : 10.1016/j.devcel.2005.02.017
Cushing's Syndrome and Bone, Pituitary, vol.30, issue.4, pp.249-52, 2004. ,
DOI : 10.1159/000061083
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength, Endocrinology. avr, vol.145, issue.4, pp.1835-1876, 2004. ,
Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3??-dependent and -independent Manner, Journal of Biological Chemistry, vol.272, issue.3, pp.2388-94, 2005. ,
DOI : 10.1086/368277
Glucocorticoid-Treated Mice Have Localized Changes in Trabecular Bone Material Properties and Osteocyte Lacunar Size That Are Not Observed in Placebo-Treated or Estrogen-Deficient Mice, Journal of Bone and Mineral Research, vol.16, issue.3, pp.466-76, 2006. ,
DOI : 10.1007/BF00427310
Glucocorticoid-Induced Bone Disease, New England Journal of Medicine, vol.365, issue.1, pp.62-70, 2011. ,
DOI : 10.1056/NEJMcp1012926
Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity, Bone, vol.46, issue.3, pp.564-70, 2010. ,
DOI : 10.1016/j.bone.2009.06.030
Bone Resorption by Osteoclasts, Science, vol.289, issue.5484, pp.1504-1512, 2000. ,
DOI : 10.1126/science.289.5484.1504
Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density, Endocrinology, vol.147, issue.12, pp.5592-5601, 2006. ,
DOI : 10.1210/en.2006-0459
Effects of Glucocorticoids on Bone: What we can Learn from Pediatric Endogenous Cushing???s Syndrome, Hormone and Metabolic Research, vol.48, issue.11, pp.764-70, 2016. ,
DOI : 10.1055/s-0042-117721
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone., Journal of Clinical Investigation, vol.102, issue.2, pp.274-82, 1998. ,
DOI : 10.1172/JCI2799
Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid-Induced and Postmenopausal Osteoporosis, Journal of Bone and Mineral Research, vol.6, issue.Suppl 1, pp.97-103, 2001. ,
DOI : 10.1093/geronj/45.5.M153
Epidemiology and outcomes of osteoporotic fractures, The Lancet, vol.359, issue.9319, pp.1761-1768, 2002. ,
DOI : 10.1016/S0140-6736(02)08657-9
Population-Based Study of Survival after Osteoporotic Fractures, American Journal of Epidemiology, vol.137, issue.9, pp.1001-1006, 1993. ,
DOI : 10.1093/oxfordjournals.aje.a116756
Bone microarchitecture as an important determinant of bone strength, Journal of Endocrinological Investigation, vol.18, issue.Suppl.1, pp.99-105, 2004. ,
DOI : 10.1210/en.2002-220149
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, issue.6, pp.493-501, 2014. ,
DOI : 10.1016/j.jbspin.2014.10.001
FRAX??? and the assessment of fracture probability in men and women from the UK, Osteoporosis International, vol.17, issue.Suppl 2, pp.385-97, 2008. ,
DOI : 10.1093/qjmed/hci029
Predictive Value of Low BMD for 1-Year Fracture Outcomes Is Similar for Postmenopausal Women Ages 50-64 and 65 and Older: Results From the National Osteoporosis Risk Assessment (NORA), Journal of Bone and Mineral Research, vol.150, issue.S1, pp.1215-1235, 2004. ,
DOI : 10.1093/oxfordjournals.aje.a010040
Bone Quality ??? The Material and Structural Basis of Bone Strength and Fragility, New England Journal of Medicine, vol.354, issue.21, pp.2250-61, 2006. ,
DOI : 10.1056/NEJMra053077
Recognizing and treating secondary osteoporosis, Nature Reviews Rheumatology, vol.44, issue.8, pp.480-92, 2012. ,
DOI : 10.1016/j.bone.2009.01.373
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update, Journal of Internal Medicine, vol.11, issue.4, pp.271-92, 1998. ,
DOI : 10.1007/s002239900014
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses, Rheumatology, vol.39, issue.12, pp.1383-1392, 2000. ,
DOI : 10.1093/rheumatology/39.12.1383
A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk, Journal of Bone and Mineral Research, vol.359, issue.6, pp.893-902, 2004. ,
DOI : 10.1017/S0714980800009934
Use of oral corticosteroids and risk of fractures, J Bone Miner Res Off J Am Soc Bone Miner Res. août, vol.20, issue.1486, pp.1487-1494, 2000. ,
Osteoblastic 11??-Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure, Journal of Bone and Mineral Research, vol.37, issue.6, pp.979-86, 2002. ,
DOI : 10.1007/978-3-642-81265-1_2
Two Polymorphisms in the Glucocorticoid Receptor Gene Directly Affect Glucocorticoid-Regulated Gene Expression, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.10, pp.5804-5814, 2005. ,
DOI : 10.1210/jc.2005-0646
BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism, Clinical Endocrinology, vol.81, issue.5, pp.636-679, 2009. ,
DOI : 10.2174/0929867043363749
Bone complications in patients with Cushing???s syndrome: looking for clinical, biochemical, and genetic determinants, Osteoporosis International, vol.8, issue.5, pp.913-934, 2014. ,
DOI : 10.1038/nrendo.2011.233
Bone Mineral Density Before and After Surgical Cure of Cushing???s Syndrome Due to Adrenocortical Adenoma: Prospective Study, World Journal of Surgery, vol.138, issue.5, pp.890-896, 2008. ,
DOI : 10.1007/BF03347198
Cushing's syndrome and bone mineral density: lowest Z scores in young patients, Neth J Med. avr, vol.65, issue.4, pp.137-178, 2007. ,
Increased risk of osteoporotic fractures in patients with Cushing's syndrome, European Journal of Endocrinology, vol.146, issue.1, pp.51-57, 2002. ,
DOI : 10.1530/eje.0.1460051
Bone Demineralization and Vertebral Fractures in Endogenous Cortisol Excess: Role of Disease Etiology and Gonadal Status, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.5, pp.1779-84, 2006. ,
DOI : 10.1210/jc.2005-0582
Recovery of Bone Mineral Density after Surgical Cure, but not by Ketoconazole Treatment, in Cushing's Syndrome, Osteoporosis International, vol.12, issue.11, pp.956-60, 2001. ,
DOI : 10.1007/s001980170025
Osteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome., Endocrine Journal, vol.50, issue.1, pp.1-7, 2003. ,
DOI : 10.1507/endocrj.50.1
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing?s syndrome, Osteoporosis International, vol.20, issue.11, pp.855-61, 2004. ,
DOI : 10.1148/radiology.200.3.8756924
Altered trabecular architecture induced by Corticosteroids: A Bone Histomorphometric Study, Journal of Bone and Mineral Research, vol.10, issue.1, pp.676-85, 1996. ,
DOI : 10.1111/j.1365-2818.1993.tb03407.x
Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma, Clinical Endocrinology, vol.102, issue.5, pp.587-93, 2002. ,
DOI : 10.1128/MCB.17.6.3181
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy, Arthritis & Rheumatism, vol.12, issue.11, pp.3224-3233, 2003. ,
DOI : 10.1093/qjmed/93.2.105
Mutiple Spontaneous Rib Fractures in Patient with Cushing's Syndrome, Journal of Bone Metabolism, vol.21, issue.4, pp.277-82, 2014. ,
DOI : 10.11005/jbm.2014.21.4.277
An unusual case of hypercortisolism with multiple weight-bearing bone fractures. Clin Cases Miner Bone Metab Off J Ital Soc Osteoporos Miner Metab Skelet Dis, sept, vol.10, issue.3, pp.213-220, 2013. ,
Generation and validation of a normative, age-specific reference curve for lumbar spine trabecular bone score (TBS) in French women, Osteoporosis International, vol.26, issue.2 ,
DOI : 10.1007/s00774-007-0793-5
Trabecular bone score (TBS) in postmenopausal African American women, Osteoporosis International, vol.29, issue.3, pp.1155-61, 2015. ,
DOI : 10.1002/jbmr.2176
Age-related normative values of trabecular bone score (TBS) for Japanese women: the Japanese Population-based Osteoporosis (JPOS) study, Osteoporosis International, vol.12, issue.6, pp.245-52, 2015. ,
DOI : 10.1186/1471-2474-12-182
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX, Journal of Bone and Mineral Research, vol.14, issue.3, pp.940-948, 2016. ,
DOI : 10.1016/j.jocd.2011.04.011
TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures, Bone, vol.79, pp.259-66, 2015. ,
DOI : 10.1016/j.bone.2015.06.007
Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: Applications in the study of human trabecular bone microarchitecture, Bone, vol.42, issue.4, pp.775-87, 2008. ,
DOI : 10.1016/j.bone.2007.11.018
Trabecular Bone Score: Where are we now?, Joint Bone Spine, vol.82, issue.5, pp.320-325, 2015. ,
DOI : 10.1016/j.jbspin.2015.02.005
Trabecular bone score (TBS): Method and applications, Bone, vol.104, 2017. ,
DOI : 10.1016/j.bone.2017.01.035
Short-term precision assessment of trabecular bone score and bone mineral density using dual-energy X-ray absorptiometry with different scan modes: an in vivo study, European Radiology, vol.16, issue.7, pp.2194-2202, 2015. ,
DOI : 10.1016/j.jocd.2013.02.005
Spine Trabecular Bone Score Precision, a Comparison Between GE??Lunar Standard and High-Resolution Densitometers, Journal of Clinical Densitometry, vol.18, issue.2, pp.226-258, 2015. ,
DOI : 10.1016/j.jocd.2014.11.003
TBS result is not affected by lumbar spine osteoarthritis, Osteoporosis International, vol.86, issue.6, pp.1759-64, 2014. ,
DOI : 10.1007/s00223-009-9322-y
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice, Bone, vol.78 ,
DOI : 10.1016/j.bone.2015.05.016
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study, Journal of Bone and Mineral Research, vol.27, issue.2, pp.2762-2771, 2011. ,
DOI : 10.1002/sim.2929
Three-Dimensional (3D) Microarchitecture Correlations with 2D Projection Image Gray-Level Variations Assessed by Trabecular Bone Score Using High-Resolution Computed Tomographic Acquisitions: Effects of Resolution and Noise, Journal of Clinical Densitometry, vol.16, issue.3, pp.287-96, 2013. ,
DOI : 10.1016/j.jocd.2012.05.001
Densitometer-Specific Differences in the Correlation Between Body Mass Index and Lumbar Spine Trabecular Bone Score, Journal of Clinical Densitometry, vol.20, issue.2, pp.233-241, 2017. ,
DOI : 10.1016/j.jocd.2016.11.003
Simulated increased soft tissue thickness artefactually decreases trabecular bone score: a phantom study, BMC Musculoskeletal Disorders, vol.18, issue.1, p.17, 2016. ,
DOI : 10.1016/j.jocd.2014.04.117
Trabecular Bone Microarchitecture Alteration in Glucocorticoids Treated Women in Clinical Routine? : A TBS Evaluation, ASBMR 31st Annual Meeting, p.129 ,
The impact of glucocorticoid therapy on trabecular bone score in older women, Osteoporosis International, vol.22, issue.3, pp.1773-80, 2015. ,
DOI : 10.1359/jbmr.061206
Bone status in glucocorticoid-treated men and women, Osteoporosis International, vol.26, issue.11, pp.39-48, 2016. ,
DOI : 10.1002/jbmr.499
Trabecular Bone Score Reflects Trabecular Microarchitecture Deterioration and Fragility Fracture in Female Adult Patients Receiving Glucocorticoid Therapy: A Pre-Post Controlled Study, BioMed Research International, vol.21, issue.3, p.4210217, 2017. ,
DOI : 10.1007/s00198-015-3211-1
The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing???s syndrome, Archives of Osteoporosis, vol.3, issue.Suppl 3, p.44, 2015. ,
DOI : 10.1530/EJE-11-0272
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA, févr, vol.25, issue.2, pp.441-447, 2014. ,
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study, Clinical Endocrinology, vol.75, issue.3, pp.302-310, 2003. ,
DOI : 10.1210/er.19.2.203
Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome, J Clin Endocrinol Metab. oct, vol.80, issue.10, pp.2859-65, 1995. ,
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study, European Journal of Endocrinology, vol.154, issue.1, pp.109-127, 2006. ,
DOI : 10.1530/eje.1.02067
Calcium metabolism, vitamin D and bone mineral density after bariatric surgery, Osteoporosis International, vol.17, issue.3, pp.757-64, 2015. ,
DOI : 10.1007/s11695-007-9063-9
Bone loss in response to long-term glucocorticoid therapy, Bone and Mineral, vol.8, issue.1, pp.39-51, 1990. ,
DOI : 10.1016/0169-6009(91)90139-Q
Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures, Clinical Endocrinology, vol.147, issue.2, pp.208-221, 2009. ,
DOI : 10.7326/0003-4819-147-8-200710160-00006
Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study, European Journal of Endocrinology, vol.160, issue.2, pp.257-64, 2009. ,
DOI : 10.1530/EJE-08-0299
High variability in baseline urinary free cortisol values in patients with Cushing's disease, Clinical Endocrinology, vol.88, issue.2, pp.261-270, 2014. ,
DOI : 10.1210/jc.2003-030234
18-66) 49/31 Z score -1.97 (-5.15 à-0.06) -1.8 (-4 à -0.36) -1.8 (-2.9 à 0.9) -3.53 (-4,9 à -3), pp.15-25 ,